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Introduction:Vascular surgery patients have multiple risk factors for renal dysfunction, but
acute kidney injury (AKI) is poorly studied in this group. The purpose of this study was to
define the incidence, risk factors, and outcomes of AKI in high-risk vascular patients.
Methods: Critically ill vascular surgery patients admitted during January–December 2012
were retrospectively analyzed with 1-year follow-up. The endpoint was AKI by established
RIFLE creatinine criteria. The primary analysis was between patients with or without
AKI, with secondary analysis of post-operative AKI. Outcomes were inpatient and 1-year
mortality, inpatient lengths of stay, and discharge renal function.
Results: One-hundred and thirty six vascular surgery patients were included, representing
27% of all vascular surgery admissions during the study period. Sixty-five (48%) developed
AKI. Independent global risk factors for AKI were diabetes, increasing critical illness sever-
ity, and sepsis. While intraoperative blood loss and hypotension were associated with
subsequent renal dysfunction, post-operative AKI rates were similar for patients under-
going aortic, carotid, endovascular, or peripheral vascular procedures. All RIFLE grades
of AKI were associated with worse outcomes. Overall, patients with AKI had signifi-
cantly increased short- and long-term mortality, longer inpatient lengths of stay, and worse
discharge renal function.
Conclusion: AKI is common among critically ill vascular surgery patients. Importantly, the
type of surgical procedure appears to be less important than intra- and perioperative man-
agement in determining renal dysfunction. Regardless of its severity, AKI is a clinically
significant complication that is associated with substantially worse patient outcomes.
Keywords: acute kidney injury, renal failure, vascular surgical procedures, perioperative outcomes, surgical
critical care
INTRODUCTION
Acute kidney injury (AKI, characterized by a serum creatinine 50%
above baseline or oliguria) is a common perioperative complica-
tion in surgical patients (1–4), and is among the most frequent
forms of organ dysfunction among the critically ill (5–7). For sur-
gical patients, AKI is associated with substantially worse outcomes,
including longer inpatient lengths of stay and increased short- and
long-term mortality (1–4, 8). Although morbidity and mortality is
highest for patients with severe renal dysfunction (3, 9–11), even
transient and relatively minor increases in serum creatinine are
associated with worse outcomes (1, 11–15).
Vascular surgery patients have unique risk factors for AKI.
High-risk comorbidities such as diabetes, hypertension, and
tobacco use are common among vascular patients (15–17), and
aortic cross-clamping, contrast-induced nephropathy, and cho-
lesterol embolization are frequent renal hazards within this
group (12, 18, 19). As a result, nearly all patients undergoing
aortic surgery have at least biochemical renal dysfunction as
demonstrated by albuminuria (20), and clinically significant AKI
occurs in up to 25% (20, 21). While AKI is well studied in select
subgroups, such as after aortic surgery (12, 20, 21), few reports
have evaluated AKI in a broad group of vascular patients (22). As
such, the epidemiology, risk factors, and outcomes that may be
important and specific to these patients remain undefined.
Critically ill surgical patients have the highest risk for renal
dysfunction (14, 23). As such, patients requiring surgical intensive
care unit (SICU) admission represent an ideal, high-risk popula-
tion to study AKI. To investigate the incidence, risk factors, and
outcomes of AKI among critically ill vascular surgery patients, we
performed a subgroup analysis of AKI in vascular surgery patients
from a 1-year SICU cohort (1). We hypothesized that AKI is com-
mon within this population, associated with specific global and
intraoperative risk factors, and is associated with worse patient
outcomes.
MATERIALS AND METHODS
This study of AKI in critically ill vascular surgery patients was
a retrospective analysis, and was approved by the University of
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Maryland, Baltimore Institutional Review Board. As a subgroup
analysis of a previously described SICU cohort (1), the purpose of
this report was to serve as a distinctly separate focus on AKI among
critically ill vascular surgery patients. Briefly, the original cohort of
SICU admissions during January–December 2012 was identified
from a prospectively maintained Acute Physiology and Chronic
Health Evaluation (APACHE) IV database (Cerner, Kansas City)
(24, 25). Clinical data was retrospectively obtained from the data-
base and by chart review, and 1-year post-discharge vital status
was determined from the Social Security Death Index (1). For
this study, additional operative, transfusion, and pharmacologic
data specific to the vascular surgery patients were abstracted from
clinical records.
Vascular surgery patients are admitted to the SICU on an indi-
vidual basis based on the need for critical care support, frequent
monitoring, administration of critical medications, or other inten-
sive care unit level care; there are no protocols or pathways that
include routine SICU admission. Institutional practices include
routine hydration with balanced crystalloid infusions for patients
who receive intravenous contrast and are assessed as being at risk
for contrast nephropathy. Intravenous bicarbonate infusions or
N -acetylcysteine are used as adjuncts at the discretion of the treat-
ing team. In the setting of myoglobinemia, aggressive hydration,
diuresis, alkalinization, and potential renal support is performed
by the critical care service. Renal replacement therapy is provided
either continuously by the critical care service or intermittently by
consulting nephrologists.
Baseline renal function was defined as the lowest serum creati-
nine (milligrams per deciliter) of: within 1 year prior to admission;
at hospital or SICU admission; or, for patients without chronic
kidney dysfunction, the Modification of Diet in Renal Disease
equation solved for creatinine based on a glomerular filtration
rate of 75 mL/min/1.73 m2 (1, 9, 26). Patients with a single inpa-
tient creatinine value, on chronic dialysis or who had prior AKI,
nephrectomy, or organ transplant were excluded. The primary
endpoint was inpatient AKI, as diagnosed and classified according
to RIFLE creatinine criteria (increase from baseline: risk ≥1.5×,
injury ≥2×, and failure ≥3×) (26). Renal recovery was defined
as a sustained decreasing creatinine below a patient’s AKI – risk
threshold for more than 24 h without renal replacement therapy
(1, 26). Medication use, comorbidities, and the presence of sep-
sis were defined by clinical documentation and APACHE IV data.
Emergency status was defined as a non-elective hospital admission
or need for emergency surgical intervention.
The primary analysis was between vascular surgery patients
with or without inpatient AKI. To evaluate surgical factors asso-
ciated with AKI, a secondary analysis comparing vascular patients
with or without post-operative AKI was performed. Outcomes
included inpatient and 1-year mortality, SICU and hospital lengths
of stay, and discharge creatinine. Two-sided Fisher exact or Pearson
chi-square tests were used to compare categorical data. Unpaired
Student’s t -test was used to analyze normally distributed con-
tinuous data, which was reported as mean± standard deviation.
Mann–WhitneyU test was used to compare non-normally distrib-
uted data, which was reported as median and interquartile range.
Factors associated with AKI on univariate analysis with a P value
<0.10 were further assessed by multivariate logistic regression
with correction for age and gender, with results given as odds
ratio (OR) and 95% confidence intervals. A P value <0.05 was
accepted as statistically significant for all analyses.
RESULTS
There were 136 vascular surgery patients within the SICU cohort,
representing 22% of the SICU cohort and 27% of all vascular
surgery admissions during the period. Eighty-three (61%) of the
patients were male, mean age was 65± 15 years, and APACHE III
score was 50± 20 (Table 1), representing significant critical ill-
ness severity. Compared to vascular patients not requiring SICU
admission, the study group had more acute limb ischemia (14 vs.
7%, P = 0.02), were more likely to receive operative management
(91 vs. 74%, P < 0.0001), and underwent more aortic procedures
(35 vs. 7%, P < 0.0001).
Acute kidney injury was common, and occurred in 65 (48%)
critically ill vascular patients (Table 2), a rate similar to other
patients in the SICU cohort (231/488, 47%;P = 0.92). Most events
Table 1 | Characteristics of vascular surgery SICU patients.
All patients,
n=136
NoAKI,
n=71
AKI,
n=65
P
Demographics
Age, years±SD 65±15 63±16 67±12 0.07
Male, n (%) 83 (61) 47 (66) 36 (55) 0.20
Black, n (%) 53 (39) 28 (39) 25 (38) 0.91
Baseline creatinine,
mg/dL±SD
0.93±0.50 0.90±0.44 0.96±0.56 0.83
Chronic kidney disease,
n (%)
18 (13) 10 (14) 8 (12) 0.76
COPD, n (%) 26 (19) 13 (18) 13 (20) 0.80
Diabetes mellitus, n (%) 40 (29) 16 (23) 24 (37) 0.07
Hypertension, n (%) 86 (63) 43 (61) 43 (66) 0.50
Peripheral arterial
disease, n (%)
35 (26) 19 (27) 11 (17) 0.17
Inpatient factors
Emergency status, n (%) 73 (54) 38 (54) 35 (54) 0.97
APACHE III score±SD 50±20 44±18 56±20 0.0002
Surgical management,
n (%)
121 (89) 63 (89) 58 (89) 0.93
Critical care and
perioperative
management
Mechanical ventilation 84 (62) 34 (48) 50 (77) 0.001
Days, median (IQR) 1 (0–3) 0 (0–2) 2 (1–6) <0.0001
Transfusion, n (%) 89 (65) 38 (54) 52 (80) 0.001
Sepsis, n (%) 13 (10) 1 (1) 12 (18) 0.001
ACEI/ARB use, n (%) 40 (29) 28 (39) 12 (18) 0.007
Myoglobinemia
>500 ng/mL, n (%)
18 (13) 12 (17) 6 (9) 0.21
P value denotes comparison to AKI and non-AKI subgroups.
AKI, acute kidney injury; COPD, chronic obstructive pulmonary disease; APACHE,
acute physiology and chronic health evaluation; ACEI, angiotensin-converting
enzyme inhibitor; ARB, angiotensin receptor blocker.
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Table 2 | Acute kidney injury event characteristics.
AKI, n=65
Present on admission, n (%) 22 (34)
Post-operative, n (%) 30 (46)
Interval, median days (IQR) 1 (1–6)
Peak creatinine, mg/dL±SD 2.03±1.22
RIFLE – risk, n (%) 39 (60)
RIFLE – injury, n (%) 14 (22)
RIFLE – failure, n (%) 12 (18)
Duration, median days (IQR) 3 (2–5)
Renal replacement therapy, n (%) 8 (12)
Renal recovery, n (%) 47 (72)
Recurrent kidney injury, n (%) 17 (36)
AKI, acute kidney injury; RIFLE, risk, injury, failure, loss, end-stage renal failure
acute kidney injury classification.
(39, 60%) were within the RIFLE – risk category, representing
relatively mild renal dysfunction. Of the patients who recov-
ered, approximately one-third developed recurrent kidney injury
during their index hospitalization.
Higher critical illness severity, mechanical ventilation, sepsis,
and blood product transfusion were associated with AKI on uni-
variate analysis (Table 1). In particular, rates of AKI increased
with the total number of transfusions. While 28% of patients
who received no transfusions developed AKI, among transfusion
quartiles (1–3, 4–7, 8–10, and 11–41 total blood products), rates
of AKI were 43, 46, 68, and 74% (P = 0.001). With multivari-
ate analysis, diabetes (OR 1.3, 1.1–1.5), APACHE III score >50
(OR 1.3, 1.1–1.6), and sepsis (OR 1.4, 1.1–1.9) remained indepen-
dently associated with developing AKI (Table S1 in Supplementary
Material). Other characteristics, including age, baseline renal func-
tion, non-diabetes comorbidities, need for surgery, and significant
myoglobinemia were not associated with renal dysfunction.
Among patients admitted with normal renal function, inpatient
administration of an angiotensin-converting enzyme inhibitor or
angiotensin II receptor blocker (which was determined by the crit-
ical care or vascular surgery team on a per-patient basis) was asso-
ciated with a lower risk for developing AKI (30 vs. 54%, P = 0.01)
on univariate analysis. In particular, while pre-admission treat-
ment was itself not associated with AKI (43 vs. 35%, P = 0.35),
among patients treated prior to admission, continued inpatient
therapy was associated with a lower rate of renal dysfunction than
if the medication was discontinued (33 vs. 69%, P = 0.01). No
other potentially modifiable variable was associated with lower
rates of AKI.
Rates of AKI were similar regardless of surgical vs. non-
operative management (Table 1). Similarly, AKI rates were similar
among patients who underwent aortic, carotid, peripheral vas-
cular, endovascular, and other procedures (45–52%; not shown).
Thirty patients developed renal dysfunction post-operatively at
a median of 1 (1–6 days) after surgery (Table 2); these patients
represented 46% of patients with AKI and 32% of patients who
underwent surgery with normal renal function (Table 3). The cat-
egory of procedure did not contribute to post-operative AKI, nor
Table 3 | Procedural and intraoperative factors of patients with or
without post-operative AKI.
NoAKI,
n=64
Post-op. AKI,
n=30
P
Elective case, n (%) 48 (75) 22 (73) 0.86
ASA classification 3 (3–4) 3 (3–4) 0.32
Procedural
Open aortic, n (%) 17 (27) 9 (30) 0.73
Cross-clamp time, min (IQR) 62 (47–103) 79 (67–92) 0.89
Peripheral vascular, n (%) 21 (33) 12 (40) 0.50
Endovascular, n (%) 8 (12) 4 (13) 1.00
Carotid, n (%) 5 (8) 2 (7) 1.00
Contrast exposure, n (%) 24 (38) 12 (40) 0.82
Intraoperative
Estimated blood loss, mL±SD 700±1000 1400±2400 0.005
Transfusion, n (%) 31 (48) 22 (73) 0.02
Total blood products,
median (IQR)
0 (0–3) 2 (0–4) 0.03
Lowest base excess, mEq/L −1.9±3.3 −3.3±4.5 0.14
Vasopressor use, n (%) 3 (5) 4 (13) 0.14
≥2 Agents, n (%) 0 3 (10) 0.01
Hourly urine output, mL±SD 220±125 200±140 0.64
AKI, acute kidney injury; ASA, American Society of Anesthesiologists physical
status classification.
did aortic cross-clamp duration for open aortic surgery. Markers
of intraoperative blood loss and hypotension were associated with
subsequent renal dysfunction. After multivariate analysis of poten-
tial intraoperative factors, the need for two or more vasopressors
(OR 2.2, 1.1–4.2) and blood loss>1000 mL (OR 1.4, 1.1–1.8) were
each associated with post-operative AKI; male gender was associ-
ated with less risk for post-operative AKI (OR 0.8, 0.7–1.0; Table
S1 in Supplementary Material).
Patients who developed AKI had significantly higher mortality
during their index hospitalization and within 1-year of discharge
(relative risk 14 and 2, respectively; Figure 1 and Table 4). Despite
experiencing relatively mild renal dysfunction, even patients with
RIFLE – risk AKI had significantly higher inpatient (18 vs. 1%,
P = 0.003) and 1-year (31 vs. 14%, P = 0.04) than patients with-
out AKI. Mortality rates appeared to increase with the severity of
renal dysfunction (inpatient: risk 18% vs. failure 42%, P = 0.09;
1-year: inpatient 31 vs. 67%, P = 0.04). Finally, AKI patients had
significantly longer SICU and hospital lengths of stay, and worse
discharge renal function. As noted in Table 2, 28% of patients with
AKI did not recover to a normal renal function.
DISCUSSION
This is one of the first studies to investigate AKI in a broad,
high-risk group of vascular surgery patients. Renal dysfunction
is common among vascular patients who require SICU admission,
regardless of their primary surgical management, and is associated
with significantly higher short- and long-term mortality, greater
resource use, and worse discharge renal function. While outcomes
are worse with higher AKI grades, even relatively minor renal
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FIGURE 1 | Inpatient and 1-year mortality after acute kidney injury.
Table 4 | Patient outcomes.
NoAKI, n=71 AKI, n=65 P
Inpatient mortality, n (%) 1 (1) 13 (20) <0.0001
1-year mortality, n (%) 10 (14) 22 (34) 0.007
SICU LOS, days (IQR) 3 (2–5) 5 (3–8) 0.0006
Hospital LOS, days (IQR) 9 (5–14) 16 (10–28) <0.0001
Discharge creatinine, mg/dL±SD 0.92±0.49 1.47±1.15 0.0002
AKI, acute kidney injury; SICU, surgical intensive care unit; LOS, length of stay.
dysfunction contributes to worse outcomes, which highlights the
importance of optimizing prevention and management of AKI. As
such, this study provides important insight into renal dysfunction
among vascular surgery patients.
Consistent with prior studies of surgical and critically ill
patients, diabetes, illness severity, and sepsis are global risk fac-
tors for AKI in vascular surgery patients (2–5, 9, 10, 15, 23, 27).
Other comorbidities, such as hypertension, peripheral arterial dis-
ease, and major surgery have been associated with greater risk for
renal dysfunction (3, 8, 15, 27). While these may contribute to
AKI in vascular surgery patients, within this population, they may
be relatively less important given their high prevalence (17). Both
intraoperative and overall blood product transfusions were asso-
ciated with AKI. While these were not independent factors after
multivariate analysis adjusting for potential confounders and may
reflect disease severity, there was a clear dose–response relation-
ship between transfusion and AKI. Other studies have implicated
transfusion as an independent risk factor for AKI, distant organ
dysfunction, and worse patient outcomes (12, 21, 28–32). While
the mechanism is unclear, blood product storage and adminis-
tration may result in deleterious inflammatory and immunologic
changes that contribute to organ dysfunction (31, 32).
Interestingly, in this cohort, the type of index procedure was
not associated with AKI. Historically, open aortic surgery, partic-
ularly supra-renal procedures, has been associated with significant
rates of renal dysfunction (20, 21, 33), particularly relative to other
vascular interventions (22). Additionally, patients presenting with
acute limb ischemia are at higher risk for AKI (22), likely due
to the effects of rhabdomyolysis and ischemia-reperfusion injury
(34). However, our data suggest that within this population of crit-
ically ill patients, comorbidities, intraoperative events, and post-
operative factors define patterns of AKI. Although not defined in
detail, the factors contributing to SICU admission and critical ill-
ness severity also likely contribute. Potentially, risk may be defined
by perioperative stratification to optimize patient selection and
management, and identify opportunities to modify selected risk
factors.
By preventing the physiologic renal arteriolar constriction
needed to maintain glomerular perfusion pressure, angiotensin-
converting enzyme inhibitor and angiotensin II receptor blockers
may contribute to acute renal dysfunction. However, inpatient
treatment with an angiotensin II pathway antagonist was asso-
ciated with a protective effect in this study. While there are mixed
results of these agents on post-operative AKI in patients with car-
diovascular risk factors (35, 36), they have an established protective
effect in patients at risk for chronic renal disease (37, 38) and
may have a role in preventing contrast nephropathy (39). Our
data suggest a beneficial effect among vascular surgery patients,
particularly those already taking an angiotensin II pathway antag-
onist. As such, further investigation of the role of these agents in
modulating or protecting against acute renal function is required.
Open aortic surgery is traditionally associated with increased
risk for post-operative renal dysfunction, and these patients are
frequently exposed to intraoperative blood loss, hypotension, and
transfusions (20–22, 33). However, in this group of critically ill vas-
cular surgery patients, global and post-operative AKI rates were
similar regardless of the classification of the type of procedure.
This may represent selection bias since our institutional practice
includes routine SICU admission after aortic surgery, but even
patients undergoing lower-risk procedures clearly have high rates
of AKI if they become critically ill. As such, while specific operative
factors affect AKI rates among patients undergoing aortic surgery
(20–22, 33), perioperative management may be just as critical for
vascular surgery patients as a population.
Acute kidney injury in critically ill vascular surgery patients
was associated with significantly worse mortality and other out-
comes, as demonstrated in similar studies (9, 12, 20, 30). While
AKI may be a marker of worse illness severity, it can contribute
directly to multi-organ dysfunction and mortality by enhancing
systemic inflammation and contributing to distant organ injury
(7, 40). Supporting the clinical significance of relatively minor
creatinine changes (13–15), even patients with RIFLE – risk AKI
had significantly increased mortality. AKI of any severity should
be recognized and managed as a high-risk complication. Among
vascular surgery patients, prevention and treatment may include
ensuring optimal resuscitation, limiting contrast exposure, aggres-
sively treating sepsis, and avoiding unnecessary blood product
transfusions.
The retrospective design of this study limited the ability to fully
account for potential confounders of important risk factors such
as patient selection, inpatient medical therapies, transfusions, and
procedural details. The use of RIFLE creatinine thresholds alone to
define and stage AKI may have missed events meeting urine out-
put criteria for renal dysfunction. Similarly, although critically ill
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patients have the greatest risk for AKI, by only analyzing vascular
patients requiring SICU admission, we may have missed a major
disease burden among those not admitted to the SICU. Certain
practices which may mitigate AKI, such as intravenous hydration
to prevent contrast nephropathy, were not assessed in this study.
While the sample represented a range of vascular pathology and
procedures, features potentially unique to our patients and prac-
tice may limit the generalizability of these findings. Despite these
limitations, incidence and impact of AKI among vascular surgery
patients is clear, and should warrant a prospective, multicenter
study to better define modifiable opportunities for prevention and
treatment.
CONCLUSION
Acute kidney injury is common and clinically significant compli-
cation in vascular surgery patients who require SICU admission,
regardless of the primary surgical management. Patients who
develop renal dysfunction have significantly greater mortality, even
with relatively minor AKI. While traditional risk factors for AKI
are common among these patients, diabetes is independently asso-
ciated with higher rates of renal dysfunction. Intraoperative blood
loss and hypotension, transfusions, critical illness severity, and
sepsis are important and potentially modifiable risk factors.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Journal/10.3389/fsurg.2015.00008/
abstract
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